- $237.48bn
- $280.79bn
- $36.75bn
Street View: Amgen builds momentum with blockbusters, biosimilars and a pipeline in waiting
U.S. RESEARCH ROUNDUP-Ametek, Ball Corp, McDonald's
Amgen Inc reports results for the quarter ended June 30 - Earnings Summary
Amgen Q2 revenue rises on strong product sales growth
Amgen second-quarter sales rise 9%, profit tops Street view
PREVIEW: Amgen climbs ahead of earnings
Brief: Kaléo Announces License Agreement With Amgen For Auto-Injector Technology
Amgen discloses data breach involving patient health information (updated)
Amgen discloses data breach, says patient information was stolen
Sarepta names former Abbvie president as CEO as Ingram retires
China's Innocare says psoriasis oral drug shows 'consistent treatment effect' in late-stage trial (updated)
Amgen submits new data to challenge FDA's proposal to withdraw Tavneos (updated)
Amgen submits new data to challenge FDA's proposal to withdraw Tavneos
Brief: Amgen Says Strongly Disagrees With FDA'S Proposal To Withdraw Tavneos From The U.S. Market
Amgen settles shareholder lawsuit claiming it hid $10.7 billion tax bill
Merck gets US FDA nod for first-in-its-class oral cholesterol drug (updated)
Merck's cholesterol pill gets US FDA approval
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel